<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04679077</url>
  </required_header>
  <id_info>
    <org_study_id>MAPOVAS</org_study_id>
    <nct_id>NCT04679077</nct_id>
  </id_info>
  <brief_title>Preoperative Microcirculation and Postoperative Outcome After Major Vascular Surgery</brief_title>
  <acronym>MAPOVAS</acronym>
  <official_title>Preoperative Microcirculation and Postoperative Outcome After Major Vascular Surgery: a Prospective Cohort Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitair Ziekenhuis Brussel</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universitair Ziekenhuis Brussel</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to determine whether there is a correlation between the&#xD;
      microcirculation measured preoperatively in patients undergoing major vascular surgery and&#xD;
      the postoperative mortality during hospitalization period. The microcirculation will be&#xD;
      measured sublingually with the Cytocam-IDF imaging technique.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">February 1, 2021</start_date>
  <completion_date type="Anticipated">February 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Patients will be split into two groups after data collection. They will receive the same treatment during the clinical trial.</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Postoperative high-sensitive troponin T (hsTnT)</measure>
    <time_frame>30 days</time_frame>
    <description>Indicator of acute coronary syndrome</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cause of death</measure>
    <time_frame>30 days</time_frame>
    <description>Causes of death</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Non-cardiovascular adverse events and serious adverse events</measure>
    <time_frame>30 days</time_frame>
    <description>Incidence of non-cardiovascular complications</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiovascular adverse events and serious adverse events</measure>
    <time_frame>30 days</time_frame>
    <description>Incidence of cardiovascular complications</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlation between preoperative microcirculation and postoperative outcome during the hospitalization period.</measure>
    <time_frame>30</time_frame>
    <description>In addition, demographic parameters (age, weight, height) and comorbidities will be taken into account.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Surgery--Complications</condition>
  <arm_group>
    <arm_group_label>Cytocam-IDF Imaging</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>All patients will undergo the same interventional test.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Cytocam-IDF imaging device</intervention_name>
    <description>Observation of the microcirculation</description>
    <arm_group_label>Cytocam-IDF Imaging</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age ≥ 18 years&#xD;
&#xD;
               -  Males and females&#xD;
&#xD;
               -  ASA III classification&#xD;
&#xD;
               -  Written informed consent obtained by the patient&#xD;
&#xD;
               -  Elective hospital admission for major vascular surgery, both open and&#xD;
                  endovascular&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Emergency surgery&#xD;
&#xD;
               -  Minor vascular procedures (e.g. varicose vein stripping; thromboembolectomy;&#xD;
                  vascular access formation)&#xD;
&#xD;
               -  Pregnancy&#xD;
&#xD;
               -  Refusal or inability to provide written informed consent (language barrier,&#xD;
                  mental retardation)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Evelien Vandeurzen, Master</last_name>
    <phone>024749237</phone>
    <email>evelien.vandeurzen@uzbrussel.be</email>
  </overall_contact>
  <location>
    <facility>
      <name>UZ Brussel</name>
      <address>
        <city>Jette</city>
        <state>Brussel</state>
        <zip>1090</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <contact>
      <last_name>Evelien Vandeurzen, Master</last_name>
      <phone>024749237</phone>
      <email>evelien.vandeurzen@uzbrussel.be</email>
    </contact>
    <investigator>
      <last_name>Hélène De Cuyper, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jan Poelaert, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>December 9, 2020</study_first_submitted>
  <study_first_submitted_qc>December 17, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 22, 2020</study_first_posted>
  <last_update_submitted>December 17, 2020</last_update_submitted>
  <last_update_submitted_qc>December 17, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 22, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>Presentations of both the study protocol and the study results will be held at conferences.&#xD;
After completion of the study and analysis of the data results will be made publicly without re striction, independent of the outcome. They will be submitted for publication to an international peer-reviewed journal.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

